SCHEMBL1704748

SCHEMBL1704748

COC(=O)C=C(C)CCC=C(C)CCC1OC1(C)C

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LSS P48449 10/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4420765 1.00 LSS (0.58) LSS
SCHEMBL119016 1.00 LSS (0.58) LSS
SCHEMBL727892 0.93 LSS (0.51) LSS
SCHEMBL119229 0.88 LSS (0.46) LSS
SCHEMBL7191948 0.88 LSS (0.46) LSS
SCHEMBL8767769 0.88 LSS (0.46) LSS
SCHEMBL8767763 0.88 LSS (0.46) LSS
SCHEMBL7191953 0.88 LSS (0.46) LSS
SCHEMBL4435563 0.86 LSS (0.56) LSS
SCHEMBL1705558 0.86 LSS (0.56) LSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060035873-A1 Methods for inducing apolipoprotein e secretion ILEX PRODUCTS, INC. 2006-02-16 US claimed
EP-1019059-A4 USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION UNIV CALIFORNIA (US) 2004-01-14 EP claimed
JP-2001509165-A 2001-07-10 JP claimed
US-6187814-B1 BY TOPICALLY AN FARNESOID X-ACTIVATED RECEPTOR (FXR) ACTIVATOR SELECTED FROM FARNESAL, ALKYL FARNESYL ETHER, ALKYL FARNESOATE, AND 7-METHYL-9-(3,3-DIMETHYLOXIRANYL)-3-METHYL-2,6-NONADIENOIC ACID, ALKYL ESTER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-02-13 US claimed
WO-2000049992-A2 USE OF FXR, PPARα AND LXRα ACTIVATORS TO TREAT ACNE/ACNEIFORM CONDITIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-08-31 WO claimed
EP-1019059-A1 USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-07-19 EP claimed
US-6071955-A TREATING TERRESTRIAL MAMMALIAN SUBJECT SUFFERING FROM A CONDITIONS OF ACNE AND ACNEIFORM CONDITIONS BY ADMINISTERING 7-METHYL-9-(3,3-DIMETHYLOXIRANYL)-3-METHYL-2,6-NONADIENOIC ACID METHYL ESTER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-06-06 US claimed
WO-1998032444-A1 USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-07-30 WO claimed
US-3941879-A Method for increasing yield of silkworm cocoons employing juvenile and moulting hormones TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1976-03-02 US claimed
CN-113647360-A Bait composition for pests 福尔肯生命科学有限公司 2021-11-16 CN disclosed
EP-2097059-B1 CLEANSING OR CARE PRODUCT HENKEL KGAA (DE) 2012-04-18 EP disclosed
EP-2167017-A2 COSMETIC STICK BASED ON A CONGEALED OIL-IN-WATER DISPERSION/EMULSION HAVING A HYDROGEL FORMER Henkel AG & Co. KGaA (DE) 2010-03-31 EP disclosed
EP-2167018-A2 COSMETIC STICK BASED ON A CONGEALED OIL-IN-WATER DISPERSION/EMULSION Henkel AG & Co. KGaA (DE) 2010-03-31 EP disclosed
US-7618956-B2 Applying to selected area of skin a dermatologically acceptable composition comprising a bile acid such as lithocholic acid, deoxycholic acid, or cholic acid in an amount effective to reduce hair growth, wherein bile acid is not ursodeoxycholic acid or chenodeoxycholic acid THE GILLETTE COMPANY (US) 2009-11-17 US disclosed
US-6071955-A TREATING TERRESTRIAL MAMMALIAN SUBJECT SUFFERING FROM A CONDITIONS OF ACNE AND ACNEIFORM CONDITIONS BY ADMINISTERING 7-METHYL-9-(3,3-DIMETHYLOXIRANYL)-3-METHYL-2,6-NONADIENOIC ACID METHYL ESTER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-06-06 US disclosed
US-6071955-A TREATING TERRESTRIAL MAMMALIAN SUBJECT SUFFERING FROM A CONDITIONS OF ACNE AND ACNEIFORM CONDITIONS BY ADMINISTERING 7-METHYL-9-(3,3-DIMETHYLOXIRANYL)-3-METHYL-2,6-NONADIENOIC ACID METHYL ESTER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-06-06 US disclosed
US-6060515-A TOPICALLY APPLYING TO MAMMALIAN SKIN OR MUCOUS MEMBRANE A BARRIER DEVELOPMENT ENHANCING AMOUNT OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPARA) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-05-09 US disclosed
US-6005086-A WHEREIN SAID POLYPEPTIDE IS A NUCLEAR RECEPTOR AND IS RESPONSIVE TO THE PRESENCE OF FARNESOID TO REGULATE THE TRANSCRIPTION OF ASSOCIATED GENE(S) THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1999-12-21 US disclosed
WO-1998032444-A1 USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-07-30 WO disclosed
US-3941879-A Method for increasing yield of silkworm cocoons employing juvenile and moulting hormones TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1976-03-02 US disclosed